Logo

Invitae

Invitae Publishes First Validation Data on MRD Assays, Laying Path to Future Clinical Expansion
Premium

The analytical validity study is the first published featuring full performance data for the firm's Personalized Cancer Monitoring technology.

People in the News at NanoString, Invitae, Telesis Bio, Biocartis, Delve Bio, Co-Diagnostics

Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of Aug. 28, 2023.

People in the News at Halo Precision Diagnostics, Invitae, Bionano Genomics, More

Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of Aug. 14, 2023.

Invitae Q2 Revenues Fall 12 Percent as Firm Lowers Full-Year Guidance

Revenue grew about 1 percent on a pro forma basis after removing about $17.5 million from Q2 2022 revenues that were related to discontinued businesses and geographies.

People in the News at Invitae, Theralink Technologies, Camena Bioscience

Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of July 3, 2023

Jun 1, 2023

GenomeWeb Top 40 Falls 7 Percent in May As Broader Market Delivers Mixed Results

May 26, 2023

People in the News at Invitae, Cepheid, Nucleai, Angle, Quantum-Si, Twist Bioscience

May 15, 2023

Jury Awards Natera $19.4M in Damages in Invitae, ArcherDx Patent Infringement Suit

May 9, 2023

Invitae Revenues Decline 5 Percent in Q1 After Company Exits Businesses, Geographies

May 5, 2023

Tesis Biosciences Prepping 'One-Stop Shop' Pharmacogenomics Panel Aimed at Consumers
Premium

Apr 3, 2023

GenomeWeb Top 40 Rises 3 Percent in March, Following Broader Market

Mar 22, 2023

Invitae, Deerfield Management Partner to Mine Test Data for Rare Disease Drug Development

Mar 21, 2023

Invitae, Epic Sign Deal to Integrate Genetic Test Results Into EMR System

Mar 17, 2023

People in the News at Invitae, Resolve Biosciences, 54gene, Arima Genomics, Accelerate Diagnostics

Mar 6, 2023

Invitae's PCM Assay for Minimal Residual Disease Detection Nabs Coverage by Blue Shield of California

Mar 1, 2023

Invitae Refinances Debt, Raises $30M as Q4 Revenues Drop 3 Percent

Feb 27, 2023

UnitedHealthcare Clamping Down on Expanded Carrier Screening, Genetic Counselors, Testing Firms Say
Premium

Jan 19, 2023

Invitae Bets on Oncology Portfolio to Drive Growth as it Streamlines, Integrates Test Services
Premium

Jan 12, 2023

JP Morgan Healthcare Conference, Day 3: Invitae, NanoString, Bio-Rad, Olink, More

Jan 9, 2023

Invitae Preliminary Q4 Revenues in Line With Wall Street Estimate

Jan 4, 2023

Losses Deep and Widespread as GenomeWeb Top 40 Drops 34 Percent in 2022

Jan 3, 2023

GenomeWeb Top 40 Down 3 Percent in December, Though More Resilient Than Broader Market

Dec 30, 2022

Top 10 Articles on GenomeWeb in 2022: Illumina, Invitae, 10x Genomics, Natera, Element, Ultima, More

Dec 21, 2022

Genomics Firms Tackle Carbon Emissions, Face Obstacles to Net-Zero Goals From Suppliers, Shipping
Premium

Dec 20, 2022

Invitae Sells Archer NGS Research Assays to Integrated DNA Technologies for $48M

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.